Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsBiosimilars Conference
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
Visiongain will be holding its 7th Annual Biosimilars Conference on October 5-7, 2010 in London, UK. The conference will allow attendees to: ? Gain insights of the competitive landscape in biosimilars: U.S., EU, and emerging markets; ? Evaluate biobetters and differentiated biosimilars as practical alternatives to biosimilars for regulated markets; ? Implement successful commercial models for biobetters and follow-on biological medicines; ? Review the global pricing and reimbursement models in the biosimilars and generics market; ? Learn the impact on biosimilars product patenting; ? Leverage licensing opportunities for biosimilars; ? Validate biomarkers and comparative immunogenicity as surrogate endpoints; and ?...Full post as published by Patent Docs on September 18, 2010 (boomark / email).
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Red or Blue: Well Likely to See Biosimilars Either Way
Administrations First Volley on Biosimilars: 7 Years of Exclusivity is Long Enough
New Pathway for Biosimilars Introduced
Patent Litigation Under a Future Biosimilars Act
Senate Committee: 12 Years of Data Exclusivity is Cool







